Myriad announces Prolaris test biopsy results from EMPATHY-P study at European Association of Urology annual meeting

Myriad Genetics, Inc. has announced that results from the EMPATHY-P clinical study of Prolaris in patients newly diagnosed with prostate cancer will be highlighted at the 30th Annual Congress of...